These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1477992)

  • 1. When do we treat hypercholesterolemia?
    Brown WV
    Clin Cardiol; 1992 Nov; 15(11 Suppl 3):III10-4; discussion III 15-7. PubMed ID: 1477992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When do we treat hypercholesterolemia?
    Brown WV
    Clin Cardiol; 1992 Nov; 15(11):III10-4; discussion III15-7. PubMed ID: 1458691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic intervention for hypercholesterolemia.
    Gotto AM
    Clin Cardiol; 1992 Nov; 15(11 Suppl 3):III18-21; discussion III22-4. PubMed ID: 1477993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
    Brewer HB
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL cholesterol: physiology, pathophysiology, and management.
    Link JJ; Rohatgi A; de Lemos JA
    Curr Probl Cardiol; 2007 May; 32(5):268-314. PubMed ID: 17481993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL; Lenz ML; Taylor AA
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training.
    Lavie CJ; Milani RV
    Arch Intern Med; 1993 Apr; 153(8):982-8. PubMed ID: 8481069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of lovastatin in hypercholesterolemic women.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Clin Ther; 1992; 14(3):390-5. PubMed ID: 1638580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of lovastatin in elderly hypercholesterolemic patients.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Clin Ther; 1992; 14(1):68-76. PubMed ID: 1576628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol treatment guidelines update.
    Safeer RS; Ugalat PS
    Am Fam Physician; 2002 Mar; 65(5):871-80. PubMed ID: 11898959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.